NovoEight IV 250 (YJ code: 6343440D1023, 250 international units 1 bottle (with dissolving solution)), manufactured by Novo Nordisk Pharma, contains Turoctocog alpha (genetically recombination). This recombinant Factor VIII is indicated for the treatment and prophylaxis of bleeding in patients of all ages with hemophilia A.
NovoEight IV 250
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →